Post-approval studies (Phase 4)Study completedNCT00984139
What this trial is testing
Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination
Who this might be right for
Hepatitis B
GlaxoSmithKline 306